Papilloedema can be the first sign of life-threatening disease. Its importance was highlighted in 2016 when optometrist, Honey Rose, was convicted of gross negligence manslaughter for not identifying papilloedema in a child who later died [1]. As the detection of papilloedema relies entirely on fundal examination and/or imaging that were relatively contraindicated among non-eyecare clinicians during the COVID-19 pandemic, we were concerned about the impact of the pandemic on hospital attendances of patients with papilloedema.